Skin Laxity Clinical Trial
Official title:
A Single Center, Double-Blinded, Split-Body, Randomized Clinical Trial of Injectable Poly-L-Lactic Acid for Volumization and Adipogenesis of the Hip Dell
Verified date | February 2022 |
Source | Goldman, Butterwick, Fitzpatrick and Groff |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To assess the safety, efficacy and subject satisfaction associated with volumization of the hip dell with injectable poly-L-lactic acid (PLLA), or Sculptra® Aesthetic (Galderma Laboratories, Fort Worth, TX).
Status | Not yet recruiting |
Enrollment | 20 |
Est. completion date | March 1, 2024 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 30 Years to 60 Years |
Eligibility | Inclusion Criteria: - Adult females aged 30 to 60 years - Subjects in good general health based on investigator's judgment and medical history - Moderate to severe hip dell volume deficit as determined by the investigators - Must be willing to give and sign an informed consent form and photographic release form - Must have a stable body weight for at least six (6) months prior to study entry - Must be willing to maintain usual sun exposure, diet, and exercise routines for the duration of the study - Subject agrees to avoid tanning or use of sunless tanner during the entire course of the study - Negative urine pregnancy test result at the time of study entry (if applicable) - For female subjects of childbearing potential, must be willing to use an acceptable form of birth control during the entire course of the study. All systemic birth control measures must be in consistent use for at least 30 days prior to study enrollment. - A female is considered of childbearing potential unless she is postmenopausal, without a uterus and/or both ovaries, or has had a bilateral tubal ligation. - Acceptable methods of birth control are: oral contraceptives, contraceptive patches/rings/implants, Implanon®, Depo-Provera®, double-barrier methods (e.g., condoms and spermicide), abstinence, and/or vasectomy of partner with a documented second acceptable method of birth control, should the subject become sexually active. - Must be willing to comply with study treatments and complete the entire course of the study Exclusion Criteria: - Liposuction to bilateral hips, flanks, thighs, buttocks during the 12-month period prior to study treatment or any time during the course of the study - Mesotherapy, dermal fillers, biostimulatory injectables, fat grafting, radiofrequency device treatments, microfocused ultrasound device treatments, laser and light-based device treatments, microneedling, cryolipolysis, high intensity focused electromagnetic energy device treatment, or surgery (i.e., lower body lift, buttocks augmentation, abdominoplasty, etc.) during the 12-month period before study treatment c) Any investigational treatment for a volume deficit of the bilateral hip dell areas during the 12-month period before the study treatment d) Massage therapy during the 3-month period before study treatment. e) Creams/cosmeceuticals and/or home therapies to promote plumping of the bilateral hip dell area during the four-week period before study treatment f) Subjects with scarring in the treatment areas g) History of thrombosis, post-thrombosis syndrome, or any vascular disorder of the bilateral lower extremities - Any history of bleeding or coagulation disorders i) Subjects with tattoos or permanent implants in the treatment areas j) Subjects with a significant history or current evidence of a medical, psychological, or other disorder that, in the investigator's opinion, would preclude enrollment into the study - Subjects with a history of or presence of any skin condition/disease (including but not limited to any visible rash, atopic dermatitis, psoriasis, actinic keratoses, keratinocyte carcinoma, melanoma, etc.) in the treatment area that might interfere with the diagnosis or evaluation of study parameters - History of keloid or hypertrophic scarring - Subjects with an active bacterial, viral, or fungal infection of the treatment areas - Subjects who spray tanned or used sunless tanners in the treatment areas four (4) weeks prior to study treatment - History of lidocaine sensitivity deemed by the investigator to preclude the subject from enrolling into the study - Subjects planning any cosmetic procedure to the treatment areas during the study period, other than the treatment that will be performed by the investigator - Presence of incompletely healed wound(s) in the treatment area - Subjects who are on an immunosuppressant or have an autoimmune condition - Female subjects who are pregnant, planning a pregnancy, or breast feeding during the study - Current participation or participation within 30 days prior to the start of this study in a drug or other investigational research study |
Country | Name | City | State |
---|---|---|---|
United States | West Dermatology Research Center/Cosmetic Laser Dermatology | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
Goldman, Butterwick, Fitzpatrick and Groff | Galderma R&D |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Histological Analysis | Comparison of measure of adipose tissue in biopsies taken from device and sham treated areas prior to baseline and at followup visits | Baseline to three months post final treatment | |
Primary | Histological Analysis | Comparison of measure of adipose tissue in biopsies taken from device and sham treated areas prior to baseline and at followup visits | Baseline to six months post final treatment | |
Primary | Volumetric Analysis | Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography | Pre-Treatment Visit 2/ Baseline | |
Primary | Volumetric Analysis | Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography | Pre-Treatment Visit 3/ Day 14 | |
Primary | Volumetric Analysis | Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography | Pre-Treatment Visit 4/ Day 44 | |
Primary | Volumetric Analysis | Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography | Pre-Treatment Visit 5/ Day 74 | |
Primary | Volumetric Analysis | Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography | Visit 6/ Day 104 | |
Primary | Volumetric Analysis | Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography | Visit 7/ Day 164 | |
Primary | Volumetric Analysis | Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography | Visit 9/ Day 254 | |
Primary | Volumetric Analysis | Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography | Visit 11/ Day 344 | |
Primary | Physician Global Aesthetic Improvement Scale | Blinded-Evaluator assessment of change in appearance of treated areas where 1 + Very Much Improved, 2 = Much Improved, 3 = Improved, 4 = No Change, and 5 = Worse | 1 Month Follow-Up visit | |
Primary | Physician Global Aesthetic Improvement Scale | Blinded-Evaluator assessment of change in appearance of treated areas where 1 + Very Much Improved, 2 = Much Improved, 3 = Improved, 4 = No Change, and 5 = Worse | 3 Month Follow-Up visit | |
Primary | Physician Global Aesthetic Improvement Scale | Blinded-Evaluator assessment of change in appearance of treated areas where 1 + Very Much Improved, 2 = Much Improved, 3 = Improved, 4 = No Change, and 5 = Worse | 6 Month Follow-Up visit | |
Primary | Physician Global Aesthetic Improvement Scale | Blinded-Evaluator assessment of change in appearance of treated areas where 1 + Very Much Improved, 2 = Much Improved, 3 = Improved, 4 = No Change, and 5 = Worse | 9 Month Follow-Up visit | |
Primary | Identification of correct Treatment Area (Right vs Left Hip) | Blinded-Evaluator performed assessment of which side received study treatment and which received sham | 9 Month Follow-Up visit | |
Secondary | Collagen Analysis | Quantitative analysis of collagen amounts based on histology | Upon analysis of biopsies collected at Day 0 and 3 and 6 Month Follow-Up visits | |
Secondary | Elastin Analysis | Quantitative analysis of elastin amounts based on histology | Upon analysis of biopsies collected at Day 0 and 3 and 6 Month Follow-Up visits | |
Secondary | Skin Thickness | Ultrasound imaging measurements of skin thickness/thickness of dermis | Day 0 and 3, 6, and 9 Month Follow-Up visits | |
Secondary | Subject Global Aesthetic Improvement Score | Subject assessment of change in appearance of treated areas rated numerically from 1 to 5 with 1 being very much improved to 5 being worse | 1, 3, 6, and 9 Month Follow-Up visits | |
Secondary | Subject Satisfaction Questionairre | Degree of subject satisfaction with treatment outcomes rated numerically from 0 to 4 with 0 being not satisfied to 4 being extremely satisfied | 1, 3, 6, and 9 Month Follow-Up visits | |
Secondary | Evaluation of Side Effects | Assessment of treatment related adverse events by Investigator | Day 44, Day 74, Day 104, Day 164, Day 178, Day 254, Day 268, Day 433 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06140628 -
A 28-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Completed |
NCT01713985 -
Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck
|
N/A | |
Completed |
NCT01971736 -
Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening
|
N/A | |
Completed |
NCT01708382 -
Feasibility Study: Lifting and Tightening of the Elbows
|
N/A | |
Completed |
NCT01708252 -
Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment
|
N/A | |
Completed |
NCT01713998 -
Treatment of the Face and Neck With Lower Ulthera System Energy Settings
|
N/A | |
Completed |
NCT04296201 -
Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology
|
N/A | |
Completed |
NCT06000839 -
A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology)
|
N/A | |
Completed |
NCT06366503 -
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
|
N/A | |
Completed |
NCT05929625 -
Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation
|
N/A | |
Terminated |
NCT01713569 -
Feasibility Study: Histological Characterization After Treatment With the Ulthera® System
|
N/A | |
Completed |
NCT01519934 -
A Retrospective Study to Evaluate the Effectiveness of the Ulthera System
|
N/A | |
Completed |
NCT05605691 -
Post-Market Lower Eyelid Treatment With Renuvion in Greece
|
N/A | |
Completed |
NCT04477187 -
Clinical Assessment of Skin Tightening and Contour Change of Submental Tissue Using Bipolar Radiofrequency Microneedling
|
N/A | |
Completed |
NCT05590364 -
Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands
|
N/A | |
Active, not recruiting |
NCT06243744 -
Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery
|
N/A | |
Completed |
NCT04146584 -
Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow
|
Phase 2 | |
Recruiting |
NCT05750901 -
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
|
N/A | |
Completed |
NCT04721600 -
Evaluation of the Evoke Radiofrequency Device for Improvement of Skin Appearance
|
N/A | |
Recruiting |
NCT06157567 -
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
|
N/A |